Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 17 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Toripalimab in combination with paclitaxel and cisplatin for treating advanced or metastatic oesophageal squamous cell cancer without previous systemic chemotherapy	Cisplatin (Platinol) , Paclitaxel (Taxol; paclitaxel albumin) , Toripalimab		Head and Neck Cancer	2023	View \| Download
Tislelizumab with etoposide and carboplatin or cisplatin for treating small-cell lung cancer	Carboplatin (Paraplatin) , Cisplatin (Platinol) , Etoposide , Tislelizumab (BGB-A317; BGBA-317)	Small-cell lung cancer (SCLC)	Lung and Respiratory Cancer	2022	View \| Download
Tislelizumab in combination with Paclitaxel, Cisplatin, and Radiotherapy for Oesophageal cancer	Cisplatin (Platinol) , Paclitaxel (Taxol; paclitaxel albumin) , Tislelizumab (BGB-A317; BGBA-317)	Squamous cell carcinoma (SCC)	Head and Neck Cancer	2022	View \| Download
Tislelizumab in combination with chemotherapy for nasopharyngeal cancer – first line	Cisplatin (Platinol) , Gemcitabine (Gemzar; gemcitabine hydrochloride) , Tislelizumab (BGB-A317; BGBA-317)	Nasopharyngeal cancer	Head and Neck Cancer	2021	View \| Download
Ramucirumab (Cyramza) + capecitabine or 5-FU + cisplatin for gastric cancer of GOJ – treatment naive for palliative chemotherapy	5-Fluorouracil , Capecitabine (Xeloda) , Cisplatin (Platinol) , Ramucirumab (Cyramza)	Gastro-oesophageal junction cancer	Gastrointestinal Cancer	2017	View \| Download
Pembrolizumab in combination with pemetrexed and cisplatin for previously untreated advanced malignant pleural mesothelioma	Cisplatin (Platinol) , Pembrolizumab (Keytruda; MK-3475) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium)	Malignant pleural mesothelioma (MPM)	Lung and Respiratory Cancer	2021	View \| Download
Pembrolizumab in combination with gemcitabine and cisplatin for previously untreated advanced/unresectable biliary tract cancer	Cisplatin (Platinol) , Gemcitabine (Gemzar; gemcitabine hydrochloride) , Pembrolizumab (Keytruda; MK-3475)	Biliary tract cancer	Gastrointestinal Cancer	2021	View \| Download
Pembrolizumab in addition to platinum therapy and radiation for unresectable locally advanced head and neck squamous cell carcinoma	Cisplatin (Platinol) , Pembrolizumab (Keytruda; MK-3475)	Head and neck cancer	Head and Neck Cancer	2019	View \| Download
Pembrolizumab in addition to cisplatin and fluorouracil for recurrent locally advanced or metastatic oesophageal cancer – First-line	5-Fluorouracil , Cisplatin (Platinol) , Pembrolizumab (Keytruda; MK-3475)	Oesophageal cancer	Head and Neck Cancer	2019	View \| Download
Pegargiminase in addition to pemetrexed and cisplatin for advanced malignant pleural mesothelioma – first line	Cisplatin (Platinol) , Pegargiminase (ADI-PEG 20) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium)	Malignant pleural mesothelioma (MPM)	Lung and Respiratory Cancer	2018	View \| Download